A Review: Suppressed Activity Of Respiratory System After Covid-19
Main Article Content
Abstract
People's lifestyles and health have undergone significant changes globally in the post-pandemic, or post-Covid-19, era. Those who took drugs during the epidemic have recovered from the negative impact that SARS COVID 2 had on their respiratory systems. Individuals have taken a variety of precautions to keep themselves safe from the infection. As a result, they realized from studying respiratory physiology that common people underwent a number of alterations during the pandemic. A number of them have noticed that when they run or perform any demanding job, their breathing becomes difficult, they pant because of respiratory issues, their heart becomes profound, and they huff because their stability is compromised. The several strategies and mechanisms employed by COVID-19 to modify respiratory conditions in humans following the pandemic have been discussed in this article.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Townsend, L., Dowds, J., O’Brien, K., Sheill, G., Dyer, A. H., O’Kelly, B., ...&Bannan, C. (2021). Persistent poor health after COVID-19 is not associated with respiratory complications or initial disease severity. Annals of the American Thoracic Society, 18(6), 997-1003.
Colson, P., Rolain, J. M., Lagier, J. C., Brouqui, P., &Raoult, D. (2020). Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. International journal of antimicrobial agents, 55(4), 105932.
Amanat, F., &Krammer, F. (2020). SARS-CoV-2 vaccines: status report. Immunity, 52(4), 583-589.
Su, W. L., Lu, K. C., Chan, C. Y., & Chao, Y. C. (2021). COVID-19 and the lungs: A review. Journal of infection and public health, 14(11), 1708-1714.
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., ...& Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet, 395(10223), 497-506.
Halpin, D. M., Singh, D., & Hadfield, R. M. (2020). Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective. European Respiratory Journal, 55(5).
Ashbaugh, D., Bigelow, D. B., Petty, T., & Levine, B. (1967). Acute respiratory distress in adults. The Lancet, 290(7511), 319-323.
Ware, L. B., &Matthay, M. A. (2000). The acute respiratory distress syndrome. New England Journal of Medicine, 342(18), 1334-1349.
Bachofen, M., &Weibel, E. R. (1977). Alterations of the gas exchange apparatus in adult respiratory insufficiency associated with septicemia. American Review of Respiratory Disease, 116(4), 589-615.
Singh, D., Agusti, A., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., ...&Vogelmeier, C. (2019). Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. European Respiratory Journal, 53(5).
STOCKLEY, R. A. (1999). Neutrophils and protease/antiprotease imbalance. American journal of respiratory and critical care medicine, 160(supplement_1), S49-S52.
GBD 2015 Chronic Respiratory Disease Collaborators. (2017). Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. Respiratory Medicine, 5(9), 691.
Soriano, J. B., Abajobir, A. A., Abate, K. H., Abera, S. F., Agrawal, A., Ahmed, M. B., ... &Vos, T. (2017). Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet Respiratory Medicine, 5(9), 691-706.
Parker, C. M., Voduc, N., Aaron, S. D., Webb, K. A., & O'Donnell, D. E. (2005). Physiological changes during symptom recovery from moderate exacerbations of COPD. European Respiratory Journal, 26(3), 420-428.
Chaudhry, S. R., Luskin, V., &Panuganti, K. K. (2022). Anatomy, abdomen and pelvis, spleen. In StatPearls [Internet]. StatPearls Publishing.
Amador, C., Weber, C., &Varacallo, M. (2022). Anatomy, thorax, bronchial. In StatPearls [Internet]. StatPearls Publishing.
Liu, M. C., Hubbard, W. C., Proud, D., Stealey, B. A., Galli, S. J., Kagey-Sobotka, A., ... & Lichtenstein, L. M. (2012). Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics: cellular, mediator, and permeability changes. American Review of Respiratory Disease.
Moore, W. C., Hasday, J. D., Meltzer, S. S., Wisnewski, P. L., White, B., &Bleecker, E. R. (2001). Subjects with mild and moderate asthma respond to segmental allergen challenge with similar, reproducible, allergen-specific inflammation. Journal of allergy and clinical immunology, 108(6), 908-914.
Dodge, J. A., Lewis, P. A., Stanton, M., &Wilsher, J. (2007). Cystic fibrosis mortality and survival in the UK: 1947–2003. European Respiratory Journal, 29(3), 522-526.
Abman, S. H., Ogle, J. W., Butler-Simon, N., Rumack, C. M., &Accurso, F. J. (1988). Role of respiratory syncytial virus in early hospitalizations for respiratory distress of young infants with cystic fibrosis. The Journal of pediatrics, 113(5), 826-830.
Petrilli, C. M., Jones, S. A., Yang, J., Rajagopalan, H., O’Donnell, L., Chernyak, Y., ...&Horwitz, L. I. (2020). Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. bmj, 369.
Liu, C., Ye, L., Xia, R., Zheng, X., Yuan, C., Wang, Z., ...& Jin, M. (2020). Chest computed tomography and clinical follow-up of discharged patients with COVID-19 in Wenzhou City, Zhejiang, China. Annals of the American Thoracic Society, 17(10), 1231-1237.
Xiong, Q., Xu, M., Li, J., Liu, Y., Zhang, J., Xu, Y., & Dong, W. (2021). Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clinical microbiology and infection, 27(1), 89-95.
WU, A., WANG, J., HAN, F., & LI, Q. (2019). Risk factors for the prognosis of acute respiratory distress syndrome in the Berlin definition. Chinese General Practice, 22(18), 2176.
Gu, S. X., Tyagi, T., Jain, K., Gu, V. W., Lee, S. H., Hwa, J. M., ...&Hwa, J. (2021). Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation. Nature Reviews Cardiology, 18(3), 194-209.
Smilowitz, N. R., Kunichoff, D., Garshick, M., Shah, B., Pillinger, M., Hochman, J. S., & Berger, J. S. (2021). C-reactive protein and clinical outcomes in patients with COVID-19. European heart journal, 42(23), 2270-2279.
Craig, T. J., Corbett, M. L., & Meadows, J. A. (2023). Improving Detection of Alpha-1 Antitrypsin Deficiency: Role of the Allergist. The Journal of Allergy and Clinical Immunology: In Practice, 11(8), 2348-2354.
SRIDHAR, P., SINGH, A., & BLACKWELL, L. M. (2023). ALPHA-1 ANTITRYPSIN DEFICIENCY-ASSOCIATED BRONCHIECTASIS WITHOUT EMPHYSEMA. CHEST, 164(4), A3975-A3976.
Pahal, P., Avula, A., & Sharma, S. (2018). Emphysema.
Pahal, P., Hashmi, M. F., & Sharma, S. (2018). Chronic obstructive pulmonary disease compensatory measures.
GBD 2015 Chronic Respiratory Disease Collaborators. (2017). Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. Respiratory Medicine, 5(9), 691.
Soriano, J. B., Abajobir, A. A., Abate, K. H., Abera, S. F., Agrawal, A., Ahmed, M. B., ... &Vos, T. (2017). Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet Respiratory Medicine, 5(9), 691-706.
Singh, D., Agusti, A., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., ...&Vogelmeier, C. (2019). Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. European Respiratory Journal, 53(5).